This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Click here to view our privacy policy.

aurora europe slider 00 nordic plant cannabis blossom Trichome 1920x610

Dedicated to serving patients and physicians across Europe

High-quality medical cannabis treatments to improve the health outcomes

aurora europe slider 03 nordic plant room cannabis 1920x610

Pharmaceutical-grade medical cannabis production in Europe

aurora europe slider 02 nordic smallplant cannabis 1920x610

Grow with us!

Do you want to work with a pioneer of the European cannabis market making a difference to patients every day? Start your career with us

aurora europe slider 01 nordic plant cannabis 1920x610

Benefits of medical cannabis

Medical cannabis can be used for a wide range of conditions. Learn more about the treatment options

Science is at the heart of what we do

Passionate about advancing science to progress medical cannabis as a treatment option for physicians

PreviousNext

What sets us apart?

Info Icons - Icon Experience
Experience

Aurora has a long history of developing and producing cannabis-based medicines. Since 2006, the company has developed more than 200 different medical products from cannabis, including dried flowers, extracts, capsules and other delivery formulations. 

Info Icons - Quality
Quality

Everything we do is geared towards ensuring high quality and consistent products for patients. We have our own state-of-the-art cultivation facilities and produce according to GACP and EU-GMP standards. 

Info Icons - Network
Network

We have a strong international network that enables us to serve patients globally and respond quickly to worldwide demands.  

Info Icons - Research
Research

We have a strong heritage in research, both in plant genetics and clinical trials. We have and continue to invest heavily into new research to treat a range of disease areas.  

aurora europe 21 vision history plant cuttings cannabis 3Teaser 438 228

Advocating for medical cannabis in Europe

Aurora is one of the world’s leading cannabinoid companies, founded in 2006 to provide patients with a proven, natural treatment to manage a range of medical conditions.

Our goal is to make it possible for medical institutions, hospitals, doctors, pharmacists and patients across Europe to access safe and reliable cannabis-based medicines. To do this, we provide physicians with the knowledge and medicines they need to create treatment plans for patients.

aurora europe home 0 map europe small 828x500

Defining the future of cannabis in Europe

Aurora is a pioneer in the medicinal cannabis industry, dedicated to helping people improve their lives. Aurora is a vertically integrated organisation across the cannabis value chain from cultivation to cannabis breeding, genetics research, product development and wholesale distribution. In Europe, we produce and supply high-quality pharmaceutical-grade medical cannabis products to patients in several European markets where cannabis has been legalised for medical purposes.

Aurora – a leader in production and distribution of medical cannabis in Europe

In 2017, we entered the German market with the acquisition of Pedanios GmbH and today we are one of the largest authorised producers and distributors of medical cannabis in Europe.  

News & Events

EVENT
aurora europe home 0 two teaserb 50 Poland 672x350

Poland: 6th congress of Palliative Medicine

Congress in Białystok
Sep 2 - 4, 2021
Audience: HCPs
Polish
NEWS
aurora europe home 0 two teaserb 50 Great Britain 672x350 2
May 20, 2021

Aurora and Grow Renew Market Access Services Agreement in the United Kingdom

With the extension of the long-standing strategic relationship between Aurora and Grow Group PLC we are improving access to cannabis-based medicines in the UK. 

NEWS
aurora_europe_14_press_press_releases_partnerships_medical_cannabis_business_3teaserb_438x225
Nov 8, 2021
Country

Aurora acquires a significant equity stake in Growery B.V.

Growery is one of 10 successful applicants for a cannabis production licence to participate in the Controlled Cannabis Supply Chain Experiment (recreational market) in the Netherlands. 

NEWS
aurora europe home 0 two teaserb 50 France pilot program 672x350
Aug 24, 2021

1st patient received medical cannabis dried flowers in the French pilot program

Early 2021 Aurora and Ethypharm were selected as the primary supplier for the entire supply of medical cannabis dried flowers to patients during the first ever French pilot program. Now the 2nd milestone was reached. 

EVENT
aurora europe home 0 two teaserb 50 Poland 672x350

Poland: 6th congress of Palliative Medicine

Congress in Białystok
Sep 2 - 4, 2021
Audience: HCPs
Polish
NEWS
aurora europe home 0 two teaserb 50 Great Britain 672x350 2
May 20, 2021

Aurora and Grow Renew Market Access Services Agreement in the United Kingdom

With the extension of the long-standing strategic relationship between Aurora and Grow Group PLC we are improving access to cannabis-based medicines in the UK. 

NEWS
aurora_europe_14_press_press_releases_partnerships_medical_cannabis_business_3teaserb_438x225
Nov 8, 2021
Country

Aurora acquires a significant equity stake in Growery B.V.

Growery is one of 10 successful applicants for a cannabis production licence to participate in the Controlled Cannabis Supply Chain Experiment (recreational market) in the Netherlands. 

NEWS
aurora europe home 0 two teaserb 50 France pilot program 672x350
Aug 24, 2021

1st patient received medical cannabis dried flowers in the French pilot program

Early 2021 Aurora and Ethypharm were selected as the primary supplier for the entire supply of medical cannabis dried flowers to patients during the first ever French pilot program. Now the 2nd milestone was reached. 

NEWS
aurora_europe_14_press_press_releases_partnerships_medical_cannabis_business_3teaserb_438x225
Nov 8, 2021
Country

Aurora acquires a significant equity stake in Growery B.V.

Growery is one of 10 successful applicants for a cannabis production licence to participate in the Controlled Cannabis Supply Chain Experiment (recreational market) in the Netherlands. 

NEWS
aurora europe home 0 two teaserb 50 France pilot program 672x350
Aug 24, 2021

1st patient received medical cannabis dried flowers in the French pilot program

Early 2021 Aurora and Ethypharm were selected as the primary supplier for the entire supply of medical cannabis dried flowers to patients during the first ever French pilot program. Now the 2nd milestone was reached. 

Other relevant topics for you

aurora europe home 0 Animation EN GMP flowerroom 3teaserb 438x225

Have you ever wondered how medical cannabis is produced?

This video explains how medical cannabis, dried flowers & extracts, are produced in high-tech production facilities under EU-GMP standards.

aurora europe home 0 physican patient 3teaserb 438x225

Opening the World to Cannabis

We believe that cannabis can improve the lives of many more people. This drives our commitment for a world where patients have access to the products they need, without stigma or prosecution.

aurora europe home 0 Aurora mountains Lake 3teaserb 438x225

Aurora Cannabis Inc.

Aurora is a pioneer in global cannabis and has been dedicated to helping people improve their health, wellness and lives since 2006.